title: [Therapy and prophylaxis of infective endocarditis].
abstract: Infective endocarditis is an infection of cardiovascular structures which is typically caused by bacteria. Despite recent medical advances mortality ranges from 20 to 25%. Without treatment, IE is a lethal disease. The mortality rate depends on several clinical factors including the causative microorganism, the time of diagnosis, and the initiation of an adequate therapeutic regimen. The diagnosis is based on positive blood culture results with identical microorganisms and the demonstration of endocardial involvement. Negative blood cultures represent a diagnostic challenge which may increase the importance of diagnostic tools such as serology and PCR. An early and targeted initiation of an antibiotic therapy after microbiologic testing is crucial for therapeutic success. The immediate cooperation of Cardiologists, Microbiologists, Infectious Disease Specialists and Cardiac Surgeons is highly recommended to allow an adequate medical and surgical treatment in complex cases.Prophylaxis appears reasonable due to the inherent high mortality. The efficacy of an antibiotic prophylaxis is, nevertheless, not rigorously proven. Even if a high efficacy is assumed, the number needed to treat is extremely high due to the low individual risk. Thus, current guidelines recommend an antibiotic prophylaxis only in patients with a high risk for an adverse outcome.
authors.affiliation: Klinik für Kardiologie, Westdeutsches Herzzentrum Essen, Universitätsklinikum Essen, Essen, Deutschland.
authors.forename: B
authors.initials: B
authors.lastname: Plicht
authors.forename: C K
authors.initials: CK
authors.lastname: Naber
authors.forename: R
authors.initials: R
authors.lastname: Erbel
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D004452:Echocardiography; D017548:Echocardiography, Transesophageal; D004696:Endocarditis / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D004697:Endocarditis, Bacterial / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D008826:Microbial Sensitivity Tests; D016133:Polymerase Chain Reaction; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents
references.citation: Medicine (Baltimore). 2003 Jul;82(4):263-73
references.pmid: 12861104
references.citation: J Clin Microbiol. 2005 Oct;43(10):5238-42
references.pmid: 16207989
references.citation: Clin Infect Dis. 2007 Feb 1;44(3):364-72
references.pmid: 17205442
references.citation: Heart. 2003 Mar;89(3):258-62
references.pmid: 12591823
references.citation: JAMA. 2002 Jul 3;288(1):75-81
references.pmid: 12090865
references.citation: Heart. 2003 Mar;89(3):241-3
references.pmid: 12591812
references.citation: Scand J Infect Dis. 2001;33(9):673-80
references.pmid: 11669225
references.citation: Clin Infect Dis. 2000 Apr;30(4):633-8
references.pmid: 10770721
references.citation: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003344
references.pmid: 16437452
references.citation: J Antimicrob Chemother. 2006 Apr;57(4):639-47
references.pmid: 16501057
references.citation: Z Kardiol. 2004 Dec;93(12):1005-21
references.pmid: 15599576
references.citation: N Engl J Med. 2006 Aug 17;355(7):653-65
references.pmid: 16914701
references.citation: Clin Infect Dis. 1998 Sep;27(3):478-86
references.pmid: 9770144
references.citation: J Hosp Infect. 2007 May;66(1):15-21
references.pmid: 17376560
references.citation: Am J Med. 1994 Mar;96(3):200-9
references.pmid: 8154507
references.citation: J Antimicrob Chemother. 2008 Jan;61(1):85-90
references.pmid: 18042628